首页> 外文期刊>Quantitative Imaging in Medicine and Surgery >Characterization of microvessels and parenchyma in in-line phase contrast imaging CT: healthy liver, cirrhosis and hepatocellular carcinoma
【24h】

Characterization of microvessels and parenchyma in in-line phase contrast imaging CT: healthy liver, cirrhosis and hepatocellular carcinoma

机译:微血管和实质在线相腺癌的表征CT:健康肝,肝硬化和肝细胞癌

获取原文
           

摘要

Background: Hepatocellular carcinoma (HCC) is a cancer with a poor prognosis, and approximately 80% of HCC cases develop from cirrhosis. Imaging techniques in the clinic seem to be insufficient for revealing the microstructures of liver disease. In recent years, phase contrast imaging CT (PCI-CT) has opened new avenues for biomedical applications owing to its unprecedented spatial and contrast resolution. The aim of this study was to present three-dimensional (3D) visualization of human healthy liver, cirrhosis and HCC using a PCI-CT technique called in-line phase contrast imaging CT (ILPCI-CT) and to quantitatively evaluate the variations of these tissues, focusing on the liver parenchyma and microvasculature. Methods: Tissue samples from 9 surgical specimens of normal liver (n=3), cirrhotic liver (n=2), and HCC (n=4) were imaged using ILPCI-CT at the Shanghai Synchrotron Radiation Facility (SSRF) without contrast agents. 3D visualization of all ex vivo liver samples are presented. To quantitatively evaluate the vessel features, the vessel branch angles of each sample were clearly depicted. Additionally, radiomic features of the liver parenchyma extracted from the 3D images were measured. To evaluate the stability of the features, the percent coefficient of variation (%COV) was calculated for each radiomic feature. A %COV Results: ILPCI-CT allows for a clearer view of the architecture of the vessels and reveals more structural details than does conventional radiography. Combined with the 3D visualization technique, ILPCI-CT enables the acquisition of an accurate description of the 3D vessel morphology in liver samples. Qualitative descriptions and quantitative assessment of microvessels demonstrated clear differences among human healthy liver, cirrhotic liver and HCC. In total, 38 (approximately 51%) radiomic features had low variation, including 11 first-order features, 16 GLCM features, 6 GLRLM features and 5 GLSZM features. The differences in the mean vessel branch angles and 3 radiomic features (first-order entropy, GLCM-inverse variance and GLCM-sum entropy) were statistically significant among the three groups of samples. Conclusions: ILPCI-CT may allow for morphologic descriptions and quantitative evaluation of vessel microstructures and parenchyma in human healthy liver, cirrhotic liver and HCC. Vessel branch angles and radiomic features extracted from liver parenchyma images can be used to distinguish the three kinds of liver tissues.
机译:背景:肝细胞癌(HCC)是预后差的癌症,大约80%的HCC病例从肝硬化产生。诊所的成像技术似乎不足以揭示肝病的微观结构。近年来,由于其前所未有的空间和对比度分辨率,相位对比度成像CT(PCI-CT)为生物医学应用开辟了新的途径。本研究的目的是使用称为线相对造影成像CT(ILPCI-CT)的PCI-CT技术,呈现人健康肝,肝硬化和HCC的三维(3D)可视化,并定量评估这些的变化组织,专注于肝脏薄壁和微血管。方法:使用ILPCI-CT在上海同步辐射设施(SSRF)上的肝硬化肝(n = 2),肝硬化肝(n = 2),肝硬化肝(n = 2)和HCC(n = 4)的组织样品进行成像。 。介绍了所有离体肝样品的3D可视化。为了定量评估容器特征,清楚地描绘了每个样品的容器分支角度。另外,测量从3D图像中提取的肝实质的辐射瘤特征。为了评估特征的稳定性,针对每个射出特征计算百分比的变异系数(%COV)。 A%COV结果:ILPCI-CT允许更清楚地看船舶的架构,并揭示比传统的射线照相更多的结构细节。结合3D可视化技术,ILPCI-CT能够获取肝脏样本中的3D血管形态的准确描述。微血管的定性描述和定量评估表明,人类健康肝,肝硬化肝脏和HCC之间的明显差异。总共38个(约51%)的射出功能变化低,包括11个一阶功能,16个GLCM功能,6个GLRLM功能和5个GLSZM功能。平均血管分支角度和3个射出特征(一阶熵,GLCM - 逆变异和GLCM-SUM熵)的差异在三组样品中具有统计学意义。结论:ILPCI-CT可以允许对人体健康肝,肝硬化肝脏和HCC中血管微观结构和实质的形态学描述和定量评价。从肝脏实质图像中提取的血管分支角度和射致特征可用于区分三种肝组织。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号